Universal genetic testing for women with newly diagnosed breast cancer in the context of multidisciplinary team care

Abstract

Universal genetic testing following the diagnosis of breast cancer detects clinically significant germline pathogenic variants that might otherwise be missed because of testing guidelines. Routine testing and reporting of pathogenic variants is feasible and acceptable for both patients and clinicians.